Changing Faces

R&D

In June/July, companies continued to reshape their leadership teams in preparation for upcoming clinical, regulatory, and commercial milestones.

Market Access

The latest Board moves reflect a focus on experience in commercialisation, corporate governance, and therapeutic development.

Sales & Marketing

The agency, consultancy, and investor segments saw a wave of senior-level appointments across April and May.

Digital

The digital, supplier, CRO, and medtech services sectors continued to see a steady flow of leadership changes during the month of May.

R&D

Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.

R&D

Boardrooms and advisory panels across biotech, pharma, digital health, and life sciences suppliers saw a wave of high‑profile additions in April.